Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)

Market Cap	10.10B -8.7%
Revenue (ttm)	15.60B -9.2%
Net Income	457.83M -60.7%
EPS	0.28 -60.7%
Shares Out	1.66B
PE Ratio	22.07
Forward PE	9.50
Dividend	0.38 (6.04%)
Ex-Dividend Date	Jun 23, 2025

Volume	38,091,000
Average Volume	31,509,072
Open	6.25
Previous Close	6.29
Day's Range	6.07 - 6.25
52-Week Range	5.74 - 8.55
Beta	0.16
RSI	36.70
Earnings Date	Apr 25, 2026

About SHA:600866

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an intermediate for food and pharmaceutical raw material; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroyi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1964
• Employees: 9,293
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600866

Financial Performance

In 2025, SHA:600866's revenue was 15.90 billion, a decrease of -8.27% compared to the previous year's 17.33 billion. Earnings were 978.89 million, an increase of 3.79%.